Green Thumb Industries (GTBIF) Change in Receivables (2019 - 2026)
Green Thumb Industries (GTBIF) reported Change in Receivables of $628000.0 for Q1 2026, up 111.69% on a YoY basis from $296659.9 in Q1 2025, and up 636.75% quarter-over-quarter from -$117000.0 in Q4 2025.
Green Thumb Industries (GTBIF) Change in Receivables (2019 - 2026) Analysis & Trends
Green Thumb Industries has reported Change in Receivables for 8 years, with the latest figure at $628000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 111.69% year-over-year to $628000.0; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (up 203.92% YoY), and the FY2025 full-year result was -$1.1 million, down 111.09% from the prior year.
- Change in Receivables for Q1 2026 stood at $628000.0, up from -$117000.0 in the prior quarter.
- The five-year high for Change in Receivables was $9.2 million in Q1 2024, with the low at -$5.4 million in Q1 2025.
- Historically, Change in Receivables has averaged $1.8 million across 5 years, with a median of $150000.0 in 2022.
- Annual changes were most pronounced in 2024 — Change in Receivables surged 76616.67% — and 2025, when it sank 158.35%.
- Green Thumb Industries' Change in Receivables stood at $150000.0 in 2022, then soared by 2784.67% to $4.3 million in 2023, then decreased by 10.58% to $3.9 million in 2024, then plunged by 103.02% to -$117000.0 in 2025, then soared by 636.75% to $628000.0 in 2026.
- The last three Change in Receivables figures came in at $628000.0 (Q1 2026), -$117000.0 (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Green Thumb Industries | - | - | 143.65 Mn | 628,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 628,000.00 |
| Mar 31, 2026 | 628,000.00 |
| Dec 31, 2025 | -117,000.00 |
| Dec 31, 2025 | -117,000.00 |
| Sep 30, 2025 | 4.94 Mn |
| Sep 30, 2025 | 4.94 Mn |
| Jun 30, 2025 | -545,000.00 |
| Jun 30, 2025 | -545,000.00 |
| Mar 31, 2025 | -5.37 Mn |
| Mar 31, 2025 | -5.37 Mn |
| Dec 31, 2024 | 3.87 Mn |
| Dec 31, 2024 | 3.87 Mn |
| Sep 30, 2024 | -372,000.00 |
| Sep 30, 2024 | -372,000.00 |
| Jun 30, 2024 | -2.85 Mn |
| Jun 30, 2024 | -2.85 Mn |
| Mar 31, 2024 | 9.21 Mn |
| Mar 31, 2024 | 9.21 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Dec 31, 2023 | 4.33 Mn |